ImmunoPrecise Antibodies Ltd.
Ownership
Ownership Structure
Who owns ImmunoPrecise Antibodies Ltd. (HYFT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.7% of the shares are freely tradable; institutional investors hold 10.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Ingalls & Snyder LLC | 6.44 | 3,035,479 | +4.4 | 06/30/2026 |
| Susquehanna International Group, LLP | 1.11 | 520,769 | -2.5 | 06/30/2026 |
| Renaissance Technologies Corp | 0.45 | 213,380 | -8.2 | 06/30/2026 |
| BlackRock Inc | 0.33 | 154,411 | +0.0 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 0.29 | 135,967 | +438.6 | 06/30/2026 |
| Bank of Montreal | 0.17 | 77,947 | +11.4 | 06/30/2026 |
| BMO Capital Markets Corp. | 0.17 | 77,947 | +11.4 | 06/30/2026 |
| Allianz Asset Management AG | 0.07 | 35,000 | +0.0 | 06/30/2026 |
| GSA Capital Partners LLP | 0.07 | 34,525 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Micro-Cap ETF | 0.28 | 131,390 | +0.0 | 10/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.